CABG Improves Outcomes in Patients With Ischemic Cardiomyopathy: 10-Year Follow-Up of the STICH Trial

The authors investigated the impact of coronary artery bypass grafting (CABG) on first and recurrent hospitalization in this population. In the STICH (Surgical Treatment for Ischemic Heart Failure) trial, CABG reduced all-cause death and hospitalization in patients with and ischemic cardiomyopathy a...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:JACC. Heart failure 2019-10, Vol.7 (10), p.878-887
Hauptverfasser: Howlett, Jonathan G, Stebbins, Amanda, Petrie, Mark C, Jhund, Pardeep S, Castelvecchio, Serenella, Cherniavsky, Alexander, Sueta, Carla A, Roy, Ambuj, Piña, Ileana L, Wurm, Raphael, Drazner, Mark H, Andersson, Bert, Batlle, Carmen, Senni, Michele, Chrzanowski, Lukasz, Merkely, Bela, Carson, Peter, Desvigne-Nickens, Patrice M, Lee, Kerry L, Velazquez, Eric J, Al-Khalidi, Hussein R
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:The authors investigated the impact of coronary artery bypass grafting (CABG) on first and recurrent hospitalization in this population. In the STICH (Surgical Treatment for Ischemic Heart Failure) trial, CABG reduced all-cause death and hospitalization in patients with and ischemic cardiomyopathy and left ventricular ejection fraction 
ISSN:2213-1779
2213-1787
DOI:10.1016/j.jchf.2019.04.018